Innovation
5 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 148 times.
| Year | Filings |
|---|---|
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 5 |
Investor mix
4 investors on record; lead investors include Epidarex Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 50% |
| Other / undisclosed | 2 | 50% |